HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA. CAPRELSA® (vandetanib) Tablets for

First Page		Document Content
Date: 2014-04-01 13:41:25 Janssen Pharmaceutica Cardiac dysrhythmia Piperazines Cyclopropanes Torsades de pointes Pimozide Moxifloxacin QT interval Haloperidol Chemistry Organic chemistry Organofluorides		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CAPRELSA safely and effectively. See full prescribing information for CAPRELSA. CAPRELSA® (vandetanib) Tablets for Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 657,01 KB Share Document on Facebook

	National Medication Safety Network Observatory Bridget Rankin UKMI Guy’s and St Thomas’ hospitals DocID: 1gjYK - View Document
	Note: This list of references was prepared to help candidates during preparation for the Diplomate in Safety Pharmacology (DSP) examination. Questions for the DSP exam were prepared by a committee composed of 16 experts DocID: 1b2uZ - View Document
	Methadone Role in TdP Questioned DocID: 19Mx5 - View Document
	A D D I C T I O N T R E A T M E N T Forum Does Methadone DocID: 19LAH - View Document
	A D D I C T I O N T R E A T M E N T Forum Cardiac Considerations DocID: 19IeI - View Document